Your browser doesn't support javascript.
loading
Different effects of baclofen on LH and cortisol responses to naloxone in normal men.
Coiro, V; Volpi, R; Marcato, A; Bertoni, P; Cavazzini, U; Caffarri, G; Capretti, L; Rossi, G; Chiodera, P.
Afiliação
  • Coiro V; Institute of Internal Medicine, School of Medicine, University of Parma, Italy.
Psychoneuroendocrinology ; 17(6): 667-71, 1992 Nov.
Article em En | MEDLINE | ID: mdl-1337607
ABSTRACT
The possible involvement of GABAergic B receptors in the control of LH and ACTH/cortisol secretion in response to naloxone was evaluated in seven normal men. Subjects were tested with naloxone (4 mg IV bolus plus 10 mg infused over 2 hr) with or without previous treatment with the gamma-aminobutyric acid (GABA)-ergic B receptor agonist, baclofen (5, 10 or 15 mg PO 30 min before naloxone). In additional experiments, six normal men were tested with 15 mg baclofen or placebo 30 min before a 2-hr infusion of normal saline. Plasma cortisol levels rose 70% in response to naloxone. The naloxone-induced cortisol rise was not modified by pretreatment with baclofen (5, 10 or 15 mg). Plasma LH concentrations rose 66% in response to naloxone. When the lowest dose of baclofen (5 mg) was administered, the LH response to naloxone remained unchanged. In contrast, 10 mg baclofen produced a significant reduction, and 15 mg baclofen completely abolished the naloxone-induced LH rise. The administration of baclofen or placebo alone did not change basal plasma levels of cortisol and LH. These data suggest that, in normal men, GABA B receptors participate in the endogenous opioidergic control of LH secretion, but not of ACTH/cortisol secretion.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Baclofeno / Hidrocortisona / Hormônio Luteinizante / Naloxona Tipo de estudo: Clinical_trials Limite: Adult / Humans / Male Idioma: En Revista: Psychoneuroendocrinology Ano de publicação: 1992 Tipo de documento: Article País de afiliação: Itália
Buscar no Google
Base de dados: MEDLINE Assunto principal: Baclofeno / Hidrocortisona / Hormônio Luteinizante / Naloxona Tipo de estudo: Clinical_trials Limite: Adult / Humans / Male Idioma: En Revista: Psychoneuroendocrinology Ano de publicação: 1992 Tipo de documento: Article País de afiliação: Itália